about
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydroca...
Read More
2.59
0.09
(3.60%)
438.5K
XNAS Volume
XNAS 17 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Equillium Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..